The Genetics Podcast

EP 195: From junk to therapy: The untapped power of regulatory RNAs with David Bumcrot of CAMP4 Therapeutics


Listen Later

Summary: 

This week on The Genetics Podcast, Patrick is joined by David Bumcrot, Chief Scientific Officer of CAMP4 Therapeutics. They discuss David’s involvement in the development of the breakthrough technologies in RNA interference and CRISPR, how CAMP4 is pioneering the use of regulatory RNAs to treat haploinsufficient diseases, and the complexities of gene regulation.

 

Show Notes: 

0:00 Intro to The Genetics Podcast

00:59 Welcome to David 

01:57 David’s experiences at companies that developed RNA interference (RNAi) and CRISPR technologies

04:05 Lessons from translating RNAi to the bedside 

05:58 The scalable chemistry of RNA versus the complexity of gene editing

07:48 Insight into the lack of rapid scalability and growth in gene therapy companies

09:19 How CAMP4 is using regulatory RNAs to boost gene expression in haploinsufficient diseases

13:01 Mapping and predicting the impact of specific regulatory RNAs on the expression of target genes

15:05 Why regulatory RNAs open up new target space without needing new drug modalities

16:27 How CAMP4 prioritizes certain diseases based on delivery feasibility and genetic evidence

18:31 Understanding expression thresholds in haploinsufficiency and building confidence in therapeutic targets

 

20:29 Comparing different approaches for increasing gene expression

22:39 Other therapeutic areas of focus for CAMP4, including urea cycle disorders and central nervous system (CNS) disorders

25:47 Lessons from early clinical development and engaging regulators on novel targets

27:47 Building high-resolution regulatory RNA maps beyond what public datasets can provide

31:04 Considerations around the treatment window for SYNGAP1

32:40 The value of collaborative frameworks for rapid therapy development 

35:20 Rethinking early safety assessment and global regulatory strategies for RNA therapies

38:37 The importance of basic science, staying optimistic, and continuing to invest in biotech innovation

40:18 Closing remarks

Find out more

  • CAMP4 Therapeutics (https://www.camp4tx.com)

Please consider rating and reviewing us on your chosen podcast listening platform! 

https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link


...more
View all episodesView all episodes
Download on the App Store

The Genetics PodcastBy Sano Genetics

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

43 ratings


More shows like The Genetics Podcast

View all
Science Friday by Science Friday and WNYC Studios

Science Friday

6,185 Listeners

Nature Podcast by Springer Nature Limited

Nature Podcast

758 Listeners

Planet Money by NPR

Planet Money

30,734 Listeners

Freakonomics Radio by Freakonomics Radio + Stitcher

Freakonomics Radio

32,071 Listeners

TED Radio Hour by NPR

TED Radio Hour

21,906 Listeners

Hidden Brain by Hidden Brain, Shankar Vedantam

Hidden Brain

43,337 Listeners

Radio Atlantic by The Atlantic

Radio Atlantic

2,278 Listeners

The Readout Loud by STAT

The Readout Loud

318 Listeners

The Next Big Idea by Next Big Idea Club

The Next Big Idea

1,273 Listeners

Short Wave by NPR

Short Wave

6,211 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

30 Listeners

People I (Mostly) Admire by Freakonomics Radio + Stitcher

People I (Mostly) Admire

2,093 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

18 Listeners

NEJM AI Grand Rounds by NEJM Group

NEJM AI Grand Rounds

52 Listeners

Ground Truths by Eric Topol

Ground Truths

50 Listeners